Yes, and it’s one of the more overlooked steps in early cancer planning. Chemotherapy and radiation can damage reproductive cells, sometimes permanently, so freezing eggs, embryos, or sperm before treatment starts is the way most patients protect that option for later. It’s a proven, established process at this point, not experimental.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “This conversation gets missed more often than it should, mostly because everyone’s focused on treating the cancer itself, understandably. But fertility preservation has a narrow window, it needs to happen before chemo or radiation starts, not after. I’d rather bring it up on day one than have a patient ask about it two years down the line.”

• Sperm banking is fast, usually done in a single visit, and doesn’t delay the start of cancer treatment by more than a day or two.
• Egg freezing takes longer, typically 10 to 14 days of hormonal stimulation before eggs can be retrieved.
• Embryo freezing follows a similar timeline to egg freezing, just with fertilisation added before storage.
• Timing has to be coordinated closely with your oncology team, since treatment can’t always wait for a full stimulation cycle.

A surgical oncologist usually flags this option early and loops in a fertility specialist before treatment planning is finalised, rather than leaving it as an afterthought.

• Not every treatment plan affects fertility the same way, some chemotherapy drugs carry higher risk than others.
• Radiation to the pelvis tends to carry more fertility risk than radiation elsewhere in the body.
• Age at the time of treatment plays a role too, particularly for egg freezing outcomes.
• Even if pregnancy feels like a distant question right now, preserving the option costs far less than trying to recover it later.

If you’re further along and thinking about the other side of this question, we’ve covered that in Is Pregnancy Safe After Cancer Treatment?, worth a read once treatment’s behind you and you’re planning the next step.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and young patients facing treatment that could affect fertility have been part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that he brings up fertility preservation on day one, before treatment planning gets finalised, rather than leaving it as something to circle back to later. That early conversation is often where things get missed elsewhere.

References

• ASCO — Clinical Practice Guidelines:
  ASCO Guidelines — Fertility Preservation
• National Cancer Institute (NCI) — Female Fertility and Cancer Treatment:
  NCI — Female Fertility and Cancer Treatment

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Yes, and it’s actually done fairly often now. Doctors call it perioperative therapy, which just means immunotherapy gets timed around the surgery itself rather than replacing it. Sometimes it’s given beforehand (neoadjuvant) to shrink the tumour down first. Sometimes after (adjuvant), to mop up whatever cells surgery couldn’t catch. Occasionally both, if the case calls for it, mainly to cut down the odds of the cancer coming back.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalorewith over 24 years of experience treating solid tumors, “Surgery removes what we can see and immunotherapy goes after what we can’t. Used together, with the right timing, they cover more ground than either one manages alone. The mistake is treating this as an either-or decision. It rarely is.”

• Given to shrink a tumour down to a size where surgery becomes safer or even possible in the first place.
• Can turn a borderline-inoperable tumour into one that’s actually removable.
• Response gets tracked through imaging before the surgery date is even fixed.
• Not every cancer type responds the same way, so this call goes through a tumour board first.

This decision follows the same underlying logic as chemo timing before surgery, just with a different drug class doing the work.

• Targets whatever microscopic cancer cells imaging couldn’t pick up after the tumour’s already out.
• Lowers the chance of recurrence, particularly in cancers with a known relapse pattern.
• Usually starts once the surgical site has had enough time to heal properly.
• Duration varies a lot, some protocols run months, others longer, depending on the cancer type and how the case responds.

A surgical oncologist coordinates this timing with the rest of the treatment team, since jumping in too early can interfere with recovery.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and cases needing immunotherapy worked into the treatment sequence, before surgery, after, or both, have been part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that every case still goes through tumour board before that sequence gets decided, surgery and medical oncology figuring it out together rather than surgery being planned in isolation. That coordination is often where things get missed elsewhere.

Not sure where immunotherapy fits into your treatment plan? Don’t let that decision get made without the full picture. Call +91 9482202240 and get someone to actually walk you through it.

Reference

Immunotherapy to Treat Cancer — National Cancer Institute
ASCO Clinical Practice Guidelines

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

For average-risk adults, routine colonoscopy screening should start at 45, not 50. That’s the shift worth knowing about. Leading Indian hospitals and global oncology bodies moved the baseline down a few years back, mainly because colorectal cancer cases in younger adults kept climbing and the old cutoff was missing too many of them.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalorewith over 24 years of experience treating solid tumors, “I’ve operated on colorectal cancer patients in their early 30s more times than I’d like. The old rule of waiting till 50 was built for a different disease pattern than what we’re actually seeing walk through the door now. Age 45 isn’t some arbitrary new number, it’s catching up to what’s actually happening.”

• Colorectal cancer in adults under 50 has been rising steadily across India, not just in the West.
• A meaningful share of new cases now show up in people in their 30s and early 40s, sometimes without any family history at all.
• Diet shifts, sedentary jobs, obesity, and processed food intake all get flagged as contributing factors, though no single one explains it fully.
• Catching it early still makes the biggest difference. Stage 1 colorectal cancer has survival rates well above 90 percent, stage 4 is a very different picture.

If any of that sounds like it might already apply to you, symptoms, family history, or otherwise, it’s worth going through our Colon Cancer treatment page directly rather than waiting on a routine screening date.

• Anyone with a first-degree relative (parent, sibling, child) who’s had colorectal cancer, screening usually needs to start 10 years before that relative’s age at diagnosis.
• People with inflammatory bowel disease, like ulcerative colitis or Crohn’s, need a different, often earlier schedule entirely.
• A history of Lynch syndrome or other hereditary colorectal cancer syndromes in the family changes the starting age significantly.
• Persistent symptoms, rectal bleeding, unexplained weight loss, or a real change in bowel habits, shouldn’t wait for any screening age at all.

This ties directly into the pattern we’ve written about before, Is Colorectal Cancer More Common in Young Indians Now?, where the shift toward younger diagnoses gets explained in more depth.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and colorectal cases have been a consistent part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that every colonoscopy referral and every confirmed diagnosis gets the same structured, diagnostic-first approach, whether it’s a routine screening or something already worrying someone. That consistency is often where things get missed elsewhere.

Got a screening question or something that’s already bothering you? Don’t let it sit there unanswered. Call +91 9482202240 and get someone to actually walk you through it.

References

• American Cancer Society — Colorectal Cancer Screening Guideline (2026):
  ACS Colorectal Cancer Screening Guidelines

• Indian Council of Medical Research (ICMR) — Colorectal Cancer Guideline:
  ICMR Guidelines — Colorectal Cancer

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Here’s the part that catches most women off guard. Pre-cervical cancer, also called cervical dysplasia, and even early-stage cervical cancer usually don’t cause any symptoms at all. There’s no lump to feel, no pain to flag it, nothing obvious that tells you something’s changing. The cells can be shifting toward cancer for years before the body gives any hint, and a Pap smear or HPV test remains the only reliable way to catch it early.

Dr. Sandeep Nayak, surgical oncologist in Bangalore, puts it plainly: “Cervical cancer is one of the few cancers we can genuinely catch before it becomes cancer at all. Waiting for symptoms defeats the entire purpose of screening. By the time symptoms appear, the disease has usually moved past the early stage.”

Once cervical cancer moves beyond the earliest stage, a few signs tend to appear. None of these confirm cancer on their own, but each one is worth getting checked rather than brushed aside.

• Unusual vaginal bleeding, including bleeding between periods, after sex, or after menopause
• Vaginal discharge that looks different than usual, sometimes watery, sometimes with a noticeable odor
• Pelvic pain that isn’t tied to your normal cycle
• Discomfort or bleeding during intercourse

These symptoms overlap with plenty of non-cancerous conditions too, so they’re not proof of anything by themselves. What they do mean is that a visit to a gynecologic oncologist is worth making sooner rather than later. Our cervical cancer treatment program covers diagnosis, staging, and surgical management for exactly this kind of workup.

Screening intervals aren’t one-size-fits-all, but general guidelines look something like this:

• A Pap smear every three years, starting in your early twenties
• An HPV test every five years, starting in your thirties
• Earlier or more frequent testing if you have a prior abnormal result or a family history
• A conversation with your gynecologist if you’re unsure which schedule applies to you

The exact interval matters less than simply not skipping it. This is really the same logic behind checking any silent warning sign early, the kind we talked about in our post on painless lumps and why absence of pain doesn’t mean absence of risk. Cervical cancer just takes that idea one step further, since even the earliest disease often gives no sign at all.

Dr. Sandeep Nayak  has spent more than two decades in surgical oncology, and gynecologic cancers, cervical cancer especially, have been a consistent part of that work. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that he stays involved after an abnormal screening result too, not just once surgery becomes the conversation. That follow-through is often where things get missed elsewhere.Got a Pap smear or HPV result that came back abnormal? Don’t let it sit in a folder somewhere. Call +91 9482202240 and get someone to actually look at it.

References

1.  WHO — Cervical Cancer Fact Sheet
2. American Cancer Society — Cervical Cancer Detection, Diagnosis & Staging

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

Somewhere between 21 and 25, most women in India can get their first Pap smear. That’s the general rule, though it does shift a bit depending on which guideline your doctor’s following. Turn 30 and things change. You’ve got three routes now, HPV test alone every 5 years, Pap smear every 3, or both together (co-testing) every 5. Results stayed normal so far? You can usually stop by 65.

According to Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “With cervical cancer, we actually get to step in before it’s even cancer yet. That’s rare. Most screening isn’t hunting for disease, it’s catching what shows up years earlier. A lot of cases we see could have been avoided entirely if someone had just gotten tested on time.”

People mix these two up constantly, so let’s just sort it out.

• Pap smear: Looks at your actual cervical cells under a microscope, hunting for early changes before they become something worse.
• HPV test: Does something else entirely. Not looking at cells at all, it’s checking whether the virus behind almost all of this is even present in the first place.
• Co-testing: Above 30, a lot of clinics just run both at once and call it this, saves you a second visit.
• Timing: HPV holds up fine at 5-year gaps. Pap needs checking more often, every 3.

Got a lump, unexpected bleeding, or pelvic pain instead of just a routine screening question? That’s a different conversation. Go through our Uterus/Cervical Cancer treatment page instead of waiting on your next scheduled test.

First thing worth knowing, abnormal doesn’t mean cancer. Not even close, most of the time.

• Positive result: A positive HPV result or an odd-looking Pap usually just means something needs a closer look, nothing more at that stage.
• Colposcopy: The cervix gets examined more carefully, and a small biopsy gets taken if anything seems worth checking further.
• Most outcomes: Plenty of these turn out to be minor changes that clear up on their own, or get treated easily while they’re still small.
• Why it matters: Catching things this early is really the whole reason regular screening matters, it’s what keeps cervical cancer from developing in the first place.

One more thing worth clearing up. Getting the HPV vaccine lowers your risk by a lot, but it doesn’t replace screening. The vaccine doesn’t cover every strain linked to cervical cancer, so vaccinated or not, the same schedule applies.

We went into more of this in an earlier post, Can the HPV Vaccine Prevent Cervical Cancer?, worth a read if you’re weighing whether to vaccinate a daughter, or get vaccinated yourself as an adult.

Dr. Sandeep Nayak has spent more than two decades in surgical oncology, and cervical cancer screening and gynecologic cancers have been a consistent part of that work throughout. He currently serves as Chairman of Oncology Services for Karnataka and heads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. What tends to matter most to patients isn’t the title though, it’s that screening advice gets the same careful look as an actual diagnosis, figuring out what’s really going on before deciding anything, rather than reaching for a generic number off the internet. That attention to the specifics is often where things get missed elsewhere.

Not sure which screening schedule actually fits you? Don’t settle for a generic answer. Call +91 9482202240 and get someone to actually walk you through it.

References

•  ICMR Guidelines — Cervix Cancer
• FOGSI GCPR — Preinvasive Lesions of Cervix

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.

A painless lump in the testicle can be an early sign of testicular cancer, but it’s far from the only explanation. Several harmless conditions produce lumps that feel very similar at first touch, and the only way to tell them apart is a proper clinical exam. What makes testicular cancer tricky is exactly this: unlike most cancers, it rarely comes with pain in its early stages, so a firm, painless nodule is often the only clue, which is why so many men either ignore it or assume it’s nothing serious.

According to Prof. Dr. Sandeep Nayak, surgical oncologist in Bangalore with over 24 years of experience treating solid tumors, “A painless lump should never be written off just because it doesn’t hurt. Pain has very little to do with how serious a lump is. What matters is how it feels, whether it’s changing, and getting it examined properly instead of waiting it out.”

Most testicular lumps turn out to be something other than cancer. A few common, non-cancerous causes include:

Epididymal cysts: Small, fluid-filled sacs that form near the epididymis. They’re usually soft and often go unnoticed until a self-exam.

Hydrocele: A buildup of fluid around the testicle that creates a swelling. It can feel like a lump but is generally painless and benign.

Varicocele: Enlarged veins within the scrotum, sometimes described as feeling like a “bag of worms.” More common on the left side.

Spermatocele: A cyst that develops in the tube behind the testicle, usually painless and slow growing.

None of these need to be diagnosed by guesswork. An ultrasound and a physical exam usually settle the question within a single visit. If cancer is suspected, our testicular cancer treatment program covers everything from diagnosis through surgical management.

There’s no safe amount of time to wait on this one. Any new lump, whether painful or not, deserves an exam within a week or two. A few signs make it more urgent:

• The lump feels hard rather than soft or cystic.
• It’s been growing over several weeks.
• There’s a sense of heaviness or dragging in the scrotum.
• Any change in the size or shape of the testicle itself.

This is really the same principle behind checking any new lump in the body, not just this one. We covered a similar situation in our post on lump in the armpit and what it could mean, where the pattern of “get it checked rather than guess” holds just as true.

Dr. Sandeep Nayak has performed over 10,200 cancer surgeries across his career, with deep experience in robotic and minimally invasive techniques for urological and solid tumor cancers. As Chairman of Oncology Services, Karnataka, and Executive Director of Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore, he brings a diagnostic-first approach to every lump or swelling a patient brings in, rather than jumping straight to worst-case assumptions.

Getting an accurate answer quickly matters more than anything else here. Call +91 9482202240 to book a consultation and get clarity on what that lump actually is.

References

1. NCI — Testicular Cancer Treatment (PDQ®)
2. AUA — Testicular Cancer Guideline

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.